Zhonghua yi xue za zhi
-
Zhonghua yi xue za zhi · Apr 2011
[Establishment of normal reference values for thromboelastography on Chinese population in Beijing].
To determine the normal values for thromboelastography (TEG) in Chinese healthy adult volunteers residing in Beijing for over three years and compare them with those of the manufacturer's. ⋯ This study supports the manufacturer's recommendation that each institute should determine its own normal reference values.
-
Zhonghua yi xue za zhi · Apr 2011
[Cohort study of remifentanil-induced hyperalgesia in postoperative patients].
To investigate the incidence of remifentanil-induced hyperalgesia and screen for the relevant influencing factors in the post-operative patients. ⋯ Ages under 16 years old, operative duration and remifentanil dose are the risk factors for postoperative remifentanil-induced hyperalgesia. Neither methods of general anesthesia nor operative sites has any effect on the occurrence of hyperalgesia.
-
Zhonghua yi xue za zhi · Apr 2011
[Effect of aspirin administration for the treatment of osteoporosis in ovariectomized rat model].
To explore the therapeutic effects of aspirin on postmenopausal osteoporosis and understand its action mechanism. ⋯ Aspirin can promote trabecular bone remodeling, improve three-dimensional structure of trabecular bone and increase bone density of cancellous in osteoporotic rats by stimulating bone formation. It may become a new drug for the treatment of osteoporosis.
-
Zhonghua yi xue za zhi · Mar 2011
Randomized Controlled Trial Comparative Study[A comparison of remifentanil versus sufentanil with target-controlled infusion in combined inhalation anesthesia for surgical patients: effects on hemodynamics and postoperative recovery].
To compare the effect of remifentanil versus sufentanil with target-controlled infusion in combination with inhalation anesthesia for surgical patients on the parameters of hemodynamics and postoperative recovery. ⋯ When combined with inhalation anesthesia, the effects on hemodynamics are similar between the patients receiving the target-controlled infusions of remifentanil and sufentanil. Remifentanil offers a shorter time to recovery of spontaneous breathing and tracheal extubation.
-
Zhonghua yi xue za zhi · Mar 2011
Comparative Study[Causes of chronic obstructive pulmonary disease-related death and influencing factors of survival time].
To study the causes of chronic obstructive pulmonary disease (COPD)-related death and influencing factors of survival time from first hospitalization due to acute exacerbation of chronic obstructive pulmonary disease (AECOPD). ⋯ The major cause of death in moderate-severe COPD patients is respiratory disease. complicated with coronary artery disease & severe pulmonary hypertension, age, BMI and serum level of CRP are the independent risk factors of affecting the survival time from first hospitalization due to AECOPD.